Other substances

Broussoflavan A

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Broussoflavan A on PubChem

 

Structure image - Broussoflavan A

CC(=CCC1=C(C2=C(C=C1[C@@H]3CCC4=C(O3)C=C(C=C4)O)C(C(C(O2)(C)C)O)O)O)C

Supporting references

Link Tested on Impact factor Notes Publication date
Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches
3CLpro Small molecule In silico Screening 		in silico 3.31

Predicted to have a higher binding affinity to SARS-CoV-2 3C-like protease than darunavir and lopinavir.

 Aug/07/2020
Export (.csv)